Three Killer Indicators Identified That Are Even Worse Than High Cholesterol
at the University of Warwick have identified a particular combination
of health problems that can double the risk of heart attack and cause a
three-fold increase in the risk of mortality.
team, led by Assistant Clinical Professor of Public Health at Warwick
Medical School Dr. Oscar Franco, has discovered that simultaneously
having obesity, high blood pressure and high blood sugar are the most
dangerous combination of health factors when developing metabolic
syndrome is a combination of medical disorders that increase the risk
of developing cardiovascular disease and diabetes.
main five health problems normally associated with metabolic syndrome
are abnormal levels of blood pressure, high cholesterol, high
triglyceride levels (the chemical form in which fat exists in the
body), too much sugar in the blood and central obesity (excess of fat
around the waistline).
study, published in the American Heart Association journal Circulation,
Franco has identified the most dangerous combination of these
conditions to be central obesity, high blood pressure and high blood
sugar. People who have all three of these conditions are twice as
likely to have a heart attack and three times more likely to die
earlier than the general population.
team looked at 3,078 people to track the prevalence and progress of
metabolic syndrome as part of the Framingham Offspring Study.
said: "Metabolic syndrome is a highly prevalent condition that is
increasing dramatically and affects a large portion of the middle-age
population. Not all individuals enter the syndrome with identical
combination of factors. Certain combinations confer higher risks of
incident cardiovascular disease and mortality."
said the combination of high blood pressure, central obesity and
hyperglycemia (high blood sugar ) showed a significantly higher risk
compared to the others.
added: "Intense efforts are needed to identify populations with these
particular combinations and to provide them with adequate treatment at
the early stages of disease."
For more information on the University of Warwick, visit www2.warwick.ac.uk.